Freeze-dried chitosan/pectin nasal inserts for antipsychotic drug delivery

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 75, Issue 3, 2010, Pages 381-387

  Luppi, Barbara ^a   Bigucci, Federica ^a   Abruzzo, Angela ^a   Corace, Giuseppe ^a   Cerchiara, Teresa ^b   Zecchi, Vittorio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Chitosan pectin polyelectrolyte complexes; Chlorpromazine hydrochloride; Mucoadhesive inserts; Nasal delivery

Indexed keywords

CHITOSAN; CHLORPROMAZINE; PECTIN; POLYANION; POLYCATION; POLYELECTROLYTE;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; FREEZE DRYING; NONHUMAN; PH; PKA; POROSITY; SHEEP;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIPSYCHOTIC AGENTS; CHITOSAN; FREEZE DRYING; MICROSCOPY, ELECTRON, SCANNING; NASAL MUCOSA; PECTINS; SHEEP;

EID: 77954533476     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.04.013     Document Type: Article

References (19)

1. Keith S. Advances in psychotropic formulations. Progr. Neuropsychopharmacol. Biol. Psychiatry 2006, 30:996-1008.
2. Illum L. Nasal drug delivery: possibilities, problems and solutions. J. Control. Release 2003, 87:187-198.
3. Andersen I., Proctor D.F. Measurement of nasal mucociliary clearance. Eur. J. Resp. Dis. 1983, 64:37-40.
4. King M. Relationship between mucus viscoelasticity and ciliary transport in guaran gel/frog palate system. Biorheology 1980, 17:249-254.
5. Nagai T., Machida Y. Bioadhesive dosage forms for nasal administration. Bioadhesive Drug Delivery Systems 1990, 169-178. CRC Press, Boca Raton, FL. V. Lenaerts, R. Gurny (Eds.).
6. Luppi B., Bigucci F., Mercolini L., Musenga A., Sorrenti M., Catenacci L., Zecchi V. Novel mucoadhesive nasal inserts based on chitosan/hyaluronate polyelectrolyte complexes for peptide and protein delivery. J. Pharm. Pharmacol. 2009, 61(2):151-157.
7. Bigucci F., Luppi B., Cerchiara T., Sorrenti M., Bettinetti G., Rodriguez L., Zecchi V. Chitosan/pectin polyelectrolyte complexes: selection of suitable preparative conditions for colon-specific delivery of vancomycin. Eur. J. Pharm. Sci. 2008, 35(5):435-441.
8. McInnes F.J., Thapa P., Baillie A.J., Welling P.G., Watson D.G., Gibson I., Nolan A., Stevens H.N.E. In vivo evaluation of nicotine lyophilised nasal insert in sheep. Int. J. Pharm. 2005, 304:72-82.
9. Chien Y.W., Su K.S.E., Chang S. Nasal systemic drug delivery. Drugs and the Pharmaceutical Sciences 1989, 1-29. Marcel Dekker, New York. Y.W. Chien (Ed.).
10. Washington N., Steele R.J.C., Jackson S.J., Bush D., Mason J., Gill D.A., Pitt K., Rawlins D.A. Determination of baseline human nasal pH and the effect of intranasally administered buffer. Int. J. Pharm. 2000, 198(2):139-146.
11. Berger J., Reist M., Mayer J.M., Felt O., Peppas N.A., Gurny R. Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications. Eur. J. Pharm. Biopharm. 2004, 57:35-52.
12. Chrzanowski F.A., McGrogan B.A., Maryanoff B.E. The pKa of butaclamol and the mode of butaclamol binding to central dopamine receptors. J. Med. Chem. 1985, 28:399-400.
13. Bertram U., Bodmeier R. In situ gelling, bioadhesive nasal inserts for extended drug delivery: in vitro characterization of a new nasal dosage form. Eur. J. Pharm. Sci. 2006, 27(1):62-71.
14. Duchene D., Touchard F., Peppas N.A. Pharmaceutical and medical aspects of bioadhesive systems for drug administration. Drug Dev. Ind. Pharm. 1988, 14:283-318.
15. Gurny R., Meyer J.M., Peppas N.A. Bioadhesive intraoral release systems: design, testing and analysis. Biomaterials 1984, 5:336-340.
16. Peppas N.A., Buri P.A. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. J. Control. Release 1985, 2:257-275.
17. Peppas N.A., Sahlin J.J. Hydrogels as mucoadhesive and bioadhesive materials: a review. Biomaterials 1996, 17:1553-1561.
18. Kumar M., Misra A., Babbar A.K., Mishra A.K., Mishra P., Pathak K. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int. J. Pharm. 2008, 358:285-291.
19. McInnes F.J., O'Mahony B., Lindsay B., Band J., Wilson C.G., Hodges L.A. Nasal residence of insulin containing lyophilised nasal insert formulations, using gamma scintigraphy. Eur. J. Pharm. Sci. 2007, 31:25-31.